The science of endpoints in the current regulatory & HTA environment – basic principles
March 2 @ 10:00 - 11:00 UTC+0
The science of endpoints in the current regulatory and HTA environment – Basic principles
Thursday, March 2, 2017 @ 10 - 11 AM EST (New York, USA)
Target Audience / Who Should Attend?:
This webinar is geared toward anyone seeking regulatory advice in the development of endpoint plans.
Host / Featured Presenter:
Rory Graham BPharm MBA - Senior Director, Regulatory Affairs, Europe & International Region, Mapi
Mr. Graham has facilitated numerous aspects of drug and medical device development during his 25 year career in the pharmaceutical, biotechnology and device industries. Mr Graham has held senior positions in the area of regulatory affairs in companies in Europe and Asia-Pacific. He has arranged and directly participated in meetings with many global agencies including FDA, EMA, PMDA, TGA and European National Agencies.
He has experience in various therapeutic areas including CNS, Oncology, Hematology, Immunology, Diabetes, Analgesia and Wound-Care. He has achieved orphan designations for pharmaceutical products in the EU, US and Australia. Mr Graham leads a talented team of regulatory professionals that produce client-specific regulatory and development strategies, as well as solutions for global and local market needs.
Register to Attend: